Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392066

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392066

Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The Rescue Inhaler Market size is expected to reach US$ 27.9 billion by 2030, from US$ 15.5 billion in 2023, at a CAGR of 8.8% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 15.5 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.80% 2030 Value Projection: US$ 27.9 Bn
Figure 1. Rescue Inhaler Market Share (%), By Region, 2023
Rescue Inhaler Market - IMG1

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Detailed Segmentation:

  • By Product Type:
    • Metered Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
    • Soft Mist Inhalers
    • Others
  • By Indication:
    • Asthma
    • COPD
    • Allergic Rhinitis
    • Pulmonary Arterial Hypertension
    • Others
  • By Patient Type:
    • Adult
    • Pediatric
  • By Dosage Form:
    • Capsules
    • Solution
    • Suspension
    • Others
  • By End User:
    • Home Care Settings
    • Hospitals & Clinics
  • By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • GSK plc.
    • Teva Pharmaceutical Industries Ltd.
    • Cipla Inc.
    • PARI Pharma GmbH
    • Lupin
    • AstraZeneca
    • Boehringer Ingelheim International GmbH.
    • Novartis
    • Pfizer
    • Sunovion Pharmaceuticals
    • 3M
    • Omron Healthcare
    • Koninklijke Philips N.V.
    • Invacare
    • Schiller
    • Teleflex Incorporated
Product Code: CMI6208

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Indication
    • Market Snippet, By Patient Type
    • Market Snippet, By Dosage Form
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of respiratory diseases
  • Increasing geriatric population
  • Increasing Product Approval
    • Restraints
  • Stringent regulatory requirements
  • Product Recall
  • High cost of inhalers
    • Opportunities
  • Rising focus on telehealth for respiratory care
  • Development of biologics for asthma
  • High growth potential in emerging markets
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Rescue Inhaler Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Metered Dose Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Dry Powder Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Soft Mist Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • COPD
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pulmonary Arterial Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • South Africa
  • Central Africa

11. Competitive Landscape

  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • PARI Pharma GmbH
  • Lupin
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Novartis
  • Pfizer
  • Sunovion Pharmaceuticals
  • 3M
  • OMRON Healthcare Co., Ltd.
  • Koninklijke Philips N.V.
  • Invacare
  • Schiller
  • Teleflex Incorporated
  • Analyst Views

12. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!